toxologics GmbH
Same addressResearch and experimental development on biotechnology
OtoJig GmbH
Feodor-Lynen-Straße 35, 30625 Hannover, DEUMaster Data
Basic information of the organization
Manufacture of irradiation, electromedical and electrotherapeutic equipmentManufacture of irradiation, electromedical and electrotherapeutic equipmentWZ 26.60.0PrimaryManufacture of power-driven hand toolsManufacture of power-driven hand toolsWZ 28.24.0Manufacture of orthopaedic appliancesManufacture of orthopaedic appliancesWZ 32.50.1
Financial Overview
Indicators extracted from public financial statements
History
Changes published in the official company registry
No events found for this filter
Management
Legal representatives of the organization
| Name | Role |
|---|---|
Samuel John since 4/3/2018 | Managing Director |
Beneficial Owners
Natural persons who ultimately own or control the company, resolved through the shareholder chain
0.00% identified100.00% unresolved
Unresolved chains (2)
| Name | Ownership |
|---|---|
MED-EL Elektromedizinische Geräte Gesellschaft mbH | 50.00% |
| 50.00% |
Shareholders
Company ownership and partner structure
2 shareholders
GmbH structure
MED-EL Elektromedizinische Geräte Gesellschaft mbH
Germany
€21,250
50.00%
Balance Sheet Accounts
Balance sheet accounts extracted from public financial statements
Financial Report
Official financial statements and annual reports
OtoJig GmbHHannoverJahresabschluss zum Geschäftsjahr vom 01.12.2022 bis zum 30.11.2023Bilanz zum 30.11.2023AKTIVA
PASSIVA
Hannover, den 18. November 2024 ANHANG zur Bilanz per 2023-11-30A) Allgemeine Angaben und Erläuterungen zum Jahresabschluss I. Anwendung des Bilanzrichtlinien-Gesetzes Auf den Jahresabschluss per 2023-11-30 finden die Vorschriften des Handelsgesetzbuches als sogenannte kleine Kapitalgesellschaften Anwendung. II. Bilanzierungs- und Bewertungsgrundsätze 1. Anlagevermögen Die Abschreibungen wurden nach der linearen Methode bewertet. Es kommen Abschreibungssätze von 6,67 %, 7,69 %, 8,33 %, 10 %, 12,5 %, 14,29 %, 20 %, 33,33 % und 100 % zur Anwendung. 2. Forderungen und sonstige Vermögensgegenstände Die Ansprüche wurden zum Nominalwert erfasst. Wertberichtigungen wurden im Bedarfsfalle vorgenommen. 3. Rückstellungen Die Rückstellungen berücksichtigen im angemessenen Umfang alle erkennbaren Risiken und gewissen Verpflichtungen. 4. Verbindlichkeiten Die Bewertung der Verbindlichkeiten erfolgte zum Rückzahlungsbetrag. B) Besondere Angaben und Erläuterungen 1. Rückstellungen Die Rückstellungen betreffen unter anderem die Aufbewahrungspflicht und die Erstellung des Jahresabschlusses 2023. C) Sonstige Angaben 1. Mitglied der Geschäftsführung Geschäftsführer im Geschäftsjahr 2022/2023 war Herr Samuel John. 2. Ergebnisverwendung Die Gesellschafterversammlung hat am 2024-08-14 beschlossen, den Bilanzverlust per 2023-11-30 in Höhe von 4.492.465,92 Euro wie folgt vorzutragen:
Hannover, 2024-11-18 Samuel
John
Anlagenspiegel zum 30.11.2023
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
News & Media Coverage
Latest news articles and media mentions
Insolvency Notices
Real-time check for insolvency notices from register courts
Current insolvency proceedings
Check if there are any insolvency proceedings for this company
Commercial Register Documents
Real-time document download from the commercial register
Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)
Organizations at this Address
Other companies registered at or near this business location
28 nearby organizations
L7 Labs GmbH
Same addressManufacture of pharmaceutical preparations
Laboremus GmbH
Same addressMedical laboratory activities
Advanced Bionics GmbH
Same addressResearch and experimental development on biotechnology
Glycothera Analytics GmbH
Same addressResearch and experimental development on biotechnology
toxogen GmbH
Same addressActivities of holding companies
Cultex Technology GmbH
Same addressResearch and experimental development on biotechnology
HörSys GmbH
Same addressResearch and experimental development on biotechnology
HörSys IP GmbH & Co. KG
Same addressActivities of holding companies
Medical laboratory activities
Activities of holding companies
Diagnostic imaging activities
Activities of holding companies
Activities of holding companies
Activities of holding companies
Management activities of other holding companies
Research and experimental development on biotechnology
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Management activities of other holding companies
Research and experimental development on biotechnology
Research and experimental development on biotechnology
Wholesale of pharmaceutical goods
Activities of holding companies
Research and experimental development on biotechnology
Financial Overview
Indicators extracted from public financial statements
Commercial Register Documents
Real-time document download from the commercial register
Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)
Insolvency Notices
Real-time check for insolvency notices from register courts
Current insolvency proceedings
Check if there are any insolvency proceedings for this company
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.